COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,693 Articles (22,913 medRxiv, 8,780 bioRxiv)

Most recent first Previous |  Page 1250: Articles 12491-12500  | Next

COVID-19 mortality in Italy varies by patient age, sex and pandemic wave
Minnai, F., De Bellis, G., Dragani, T. A., Colombo, F.
10.1101/2021.10.01.21264359 — Posted: 2021-10-02 Discussion: Onsite
COVID-19 in twins: What can we learn from them
Castro, M. V., Silva, M. V. R., Naslavsky, M. S., Santos, K. S., Magawa, J. Y., Cunha-Neto, E., Passos Bueno, M. R., Zatz, M.
10.1101/2021.09.29.21263145 — Posted: 2021-10-02 Discussion: Onsite
Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients
Fung, K. W., Baik, S., Baye, F., Zheng, Z., Huser, V., McDonald, C.
10.1101/2021.09.28.21264186 — Posted: 2021-10-01 Discussion: Onsite
Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern
Jeong, G. U., Yoon, G. Y., Moon, H. W., Lee, W., Hwang, I., Kim, H. S., Kim, K.-D., Kim, C., Ahn, D.-G., Kim, B.-T., Kim, S.-J., Kwon, Y.-C.
10.1101/2021.09.30.462687 — Posted: 2021-10-01
ZBP1 induces inflammatory signaling via RIPK3 and promotes SARS-CoV-2-induced cytokine expression
Peng, R., Wang-Kan, X., Idorn, M., Zhou, F. Y., Orozco, S. L., McCarthy, J., Leung, C. S., Lu, X., Bagola, K., Rehwinkel, J., Oberst, A., Maelfait, J., Paludan, S. R., Gyrd-Hansen, M.
10.1101/2021.10.01.462460 — Posted: 2021-10-01
COVID-19 Pandemic Response in a Migrant Farmworker Community: Excess Mortality, Testing Access and Contact Tracing in Immokalee, Florida
Limaye, N., Ninesling, B., Marcelin, F., Nolan, C., Sobba, W., Hing, M., Ptaszek, E., Leandre, F., Palazuelos, D.
10.1101/2021.10.01.21264382 — Posted: 2021-10-01
Telemedicine and molecular Sars-CoV-2 early detection to face the COVID-19 pandemic
Cherem, J., Pylro, V. S., Poles, K., Carvalho, R. C., Carvalho, E., Anacleto, J., Alvarenga, I. M., Alvarenga, D. R., Teixeira, K. d. S., Castro, J. C., Torquete, M. A., Barcante, J. M.
10.1101/2021.09.29.21264314 — Posted: 2021-10-01
Predicting the unpredictable: how dynamic COVID-19 policies and restrictions challenge model forecasts
Houdroge, F., Palmer, A., Delport, D., Walsh, T., Kelly, S. L., Hainsworth, S. W., Abeysuriya, R. G., Stuart, R. M., Kerr, C. C., Coplan, P., Wilson, D. P., Scott, N.
10.1101/2021.09.30.21264273 — Posted: 2021-10-01
Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis
Lee, A. R. Y. B., Wong, S. Y., Chai, L. Y. A., Lee, S. C., Lee, M., Muthiah, M. D., Tay, S. H., Teo, C. B., Tan, B. K. J., Chan, Y. H., Sundar, R., Soon, Y. Y.
10.1101/2021.09.28.21264126 — Posted: 2021-10-01
Humoral and cellular immune responses upon SARS-CoV-2 vaccines in patients with anti-CD20 therapies: A systematic review and meta-analysis of 1342 patients
Schietzel, S., Anderegg, M., Limacher, A., Born, A., Horn, M., Maurer, B., Hirzel, C., Sidler, D., Moor, M. B.
10.1101/2021.09.30.21264335 — Posted: 2021-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).